We recently reported that human erythroid precursor cells possess specific membrane receptors that bind and internalize acid isoferritin. Here we show that ferritin uptake by these cells is highly regulated and that the internalized ferritin-iron is used for heme synthesis and thus, this process could constitute a physiological pathway for iron assimilation. Ferritin was internalized by a specific, saturable process, distinct from the uptake of iron associated with albumin. Ferritin uptake downregulated transferrin-receptor expression, indicating that internalized ferritin-iron was recognized as an integral part of the cellular iron content. Ferritin receptor expression was coordinated HE CURRENT CONCEPT of iron uptake by erythroid cells involves binding of diferric transferrin (Tf) to cell surface receptors (TfR). The ligand-receptor complex is internalized and, after the acidification of the endosome, iron is released and the receptor is recycled to the cell surface.'
to cell development and was tightly regulated by cellular iron status. Receptor abundance was increased by irondepletion and decreased by iron-loading, while the affinity of the ferritin receptor for acid isoferritin remained nearly constant (b = 4.1 * 0.5 x lo-' mol/L). Under all experimental conditions, ferritin-and transferrin-receptor expression was closely coordinated, suggesting that these pathways possess a common regulatory element. It is concluded that ferritin uptake by erythroid cells constitutes an iron uptake pathway in addition to the classical transferrin uptake pathway.
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units (basic iso-ferritin). The biosynthesis of Ft is strictly regulated by cellular iron status.'-' Its mRNA contains an IRE structure similar to that of the TfR mRNA; however, the Ft-IRE is contained on the 5' end of the mRNA, and IRP binding inhibits Ft synthesis.
Bessis and Breton-Gorius" proposed, on the basis of electron microscopy studies, that guinea pig erythroblasts obtain Ft directly from reticuloendothelial cells with which they are associated in the bone marrow. The investigators suggested that the process involved a special type of micropinocytosis, which they termed rhopheocytosis.
A cellular receptor for acid iso-ferritin has been reported for myeloid and lymphoid cell lines."." It was suggested that this receptor is involved in the regulation of cell proliferation and differentiation, but does not serve to internalize Ft.I4 Ft receptors (F&) were also found on erythroid cells's"x and were shown to facilitate Ft-uptake in reticulocytes from guinea pigs, but not from rats." Recently, Fargion et all' showed that human recombinant H-type iso-ferritin binds to early human erythroid cells with the consequent suppression of cell proliferation. We have reported that cultured normal human erythroid precursors at the developmental stage of polychromatic normoblasts possess receptors that bind and internalize acid iso-femtin without inhibiting cell proliferation."
For Ft internalization to be a physiological iron delivery pathway in developing erythroid cells, the internalized Ftiron should be recognized by the cell as an integral part of its iron store. It should be available for cellular functions such as heme synthesis, be tightly regulated by the cellular iron status, and be capable of modulating further iron uptake in concert with the Tf pathway.
Our present study shows that Ft-uptake is regulated in early erythroid cells. Ft-uptake is regulated at the level of the abundance of surface FtR by the cellular iron status and by the iron requirement during maturation. Ferritin uptake downregulates TW expression and the internalized Ft iron is used for heme synthesis.
MATERIALS AND METHODS
Cell cultures. The 2-phase liquid culture described by Fibach et peripheral blood were separated on a gradient of Ficoll-hypaque (density, 1.077 g/mL; Pharmacia, Uppsala, Sweden). The cells were alz".z' was used. In short, mononuclear cells derived from normal each performed in triplicate.
Fe-ferritin.
cultured in a-minimal essential medium supplemented with 10% fetal calf serum (both from GIBCO, Grand Island, NY), 1 pg X mL-l cyclosporin A (Sandoz, Basel, Switzerland) and 10% conditioned medium, collected from cultures of the 5637 bladder-carcinoma cell line. The cultures were incubated at 37°C in 5% CO2 and in extra humidity. After 6 days, the nonadherent cells were harvested, washed, and recultured in fresh a-medium supplemented with 30% fetal calf serum, 1% deionized bovine serum albumin (BSA), m o m 2-mercaptoethanol, 1.5 mmoVL glutamine, m o m dexamethasone, 1 U X m l -l human recombinant erythropoietin (Cilag AG, Schaffhausen, Switzerland). After 5 days of incubation in the secondary culture, proerythroblasts were separated, as previously described:0.21 on a solution of 45% Percoll (Phannacia), resuspended in the original culture medium and incubation was continued. Cells were used for the experiments at the designated times (days 5 to 12) after the addition of erythropoietin (phase 11). At 12 days, more than 98% of the cells were nucleated erythroid precursors and more than 90% at the stage of polychromatic or orthochromatic normoblasts. With the above described culture conditions, only a minor number of reticulocytes could be obtained.
Preparation of ferritin and apolferritin. Ft was isolated from human term placenta and fractionated into iso-ferritins as previously described?' The iso-femtin used in the present experiments was the "Acid I" fraction, which has the most acidic Pi. Apo-femtin was prepared by reduction of the iron core of the Ft. Human acid isofemtin was dialyzed overnight against a 500-fold excess (voYvol) of 0.2 m o m acetate buffer (pH, 5.5) containing 1% thioglycolate and 10 mmol/L 2,2'-bipyridyl, at 4°C. It was subsequently dialyzed four times against 0.2 m o m acetate buffer (pH, 5.5) and twice against 10 mmoln 3-[N-morpholino] propane sulfonic acid (MOPS) buffer (pH, 7.0).
Preparation of "Fe-labeled proteins. Apo-Ft was loaded with '%e in 0.2 mol/L MOPS buffer (pH 7.0) using a mixture of 5% 'Ve(III), as 'VeCl3 (Amersham, Cardiff, Great Britain) and 95% Fe(II), as unlabeled ferrous ammonium sulfate. Loading was done in the presence of 100 U/mL catalase to prevent detrimental free radical reactions. Aliquots of the 5%e solution, providing a final concentration of 0.1 mmoVL Fe each, were added to a solution containing 0.25 mg/mL apo-ferritin to give a total of 800 to 1, OOO Fe-atoms per Ft molecule. Ft loading was followed spectroscopically at 310 nm, each aliquot of Fe(I1) was added only after the previous was completely oxidized.
Highly purified human albumin, human apo-Tf, and diferric Tf were obtained from Kamada Ltd, part of the RAD Chemicals Group Ltd, Rehovot, Israel. 59Fe-albumin was prepared as described above for 5%e-Ft, substituting an equivalent amount (wthol) of apo-Ft for human serum albumin. '9Fe-Tf was prepared by adding an aliquot of the 59Fe(II) solution described above to an aqueous nitrilotriacetate solution at a molar ratio of 1:2. The solution was neutralized with MOPS (0.1 m o a final concentration) and human apo-Tf was added to provide final concentrations of 0.4 mmoVL Tf and 0.8 mmom iron. All iron-protein solutions were sterilized by filtration immediately after preparation.
The purity of the products was determined by gel electrophoresis. Samples were mixed with loading buffer containing 0.5% sodium dodecyl sulfate (SDS) and incubated for 30 minutes at room temperature. The samples were then subjected to nonreducing SDS-polyacrylamide gel electrophoresis on 5% (T) polyacrylamide gels. Iron was visualized by autoradiography and protein by coomassie brilliant blue staining. The results (not shown) indicated that '9Fe-Ft, "FeTf, and 'Ve-albumin produced three distinct bands. A particular concern was the possible presence of Tf in the albumin preparation. However, on an overloaded and overexposed gel, we did not observe any label that was not albumin and could be attributed to 59Fe-Tf. When 'Te-albumin and '9Fe-Tf were mixed, they produced two distinct bands, showing that Fe-albumin did not trap Tf and did not prevent it from migrating freely.
Uptake and use of iron by cultured erythroid cells. Cells were washed and suspended at a density of 4 to 6 X 106/mL in serumfree medium containing 2% BSA. The cultures were incubated for 21 hours with 8 nmoUL "Fe-Ft containing 6.5 mmollL labeled iron or with an equivalent amount of 59Fe associated with either albumin or Tf. Parallel cultures were incubated with 59Fe-Ft or albumin and 800 nmol/L unlabeled Fe-Ft or Fe-albumin (to compete for binding and uptake and to determine nonspecific binding and uptake). '9Fe uptake was determined by y-counting of the washed cells. Cellular heme was extracted essentially as described by ThunellZ3: 1.5 mL of 1 N HCI was added to 1.0 mL cells and extracted twice with 1.5 mL ethy1acetate:acetic acid, 3:l. The organic extracts were pooled and their 59Fe content was determined by y-counting. Nonheme iron was not extracted by this method, and the recovery of heme-iron was at least 99%.
Radio-iodination procedure. Placental iso-ferritin and diferric Tf were iodinated with "'1 (as sodium iodine, Amersham, Cardiff, UK) by solid phase enzymatic radio-iodination with "Enzymobead" (Bio-Rad Laboratories, Richmond, CA) accordmg to the procedure described by the manufacturer. Iz5I-Ft was separated from free iodine on a 20 mL Biogel P-6 DG column (BioRad) and extensively dialyzed. The concentration of the radio-iodinated Ft was measured by fluorogenic enzyme-linked immunosorbent assay (ELISA).24 Using this procedure, 50% of the immunoreactivity of iodinated iso-ferritin protein decayed (because of radiodamage) after 142 days (tln = 142).25 Free iodine was estimated by trichloracetic acid (TCA) precipitation and was usually less than 5%. Free iodine did not affect the level of the specific binding of '"I-Ft as measured by Ft binding with different amounts of added labeled free iodine.
Receptor binding assay. The cells were washed four times with ice-cold RPMI-1640 medium and suspended in serum-free medium composed of RPMI 1640, 2% BSA, and 25 mmol/L HEPES (pH, 7.4). Binding to surface receptors was determined in the presence of 0.1% NaN, to inhibit receptor-ligand internalization. TW was measured by incubating cells for 60 minutes with 100 nmol/L "'1-diferric Tf, with (nonspecific binding) or without (total binding) a 200-fold excess of unlabeled difenic Tf. F@ was measured by incubating cells with various concentrations of 12sI-labeled acidic placental iso-femtin in the presence and absence of a 100-fold excess of unlabeled Ft." In both assays, following incubation with the radioligand, the cells were washed four times, transferred to new tubes and counted in a y-counter. Specific binding was calculated by deducting the nonspecific binding from the total. The binding of '"I-Ft and of '"I-Tf were determined and the receptor affinities were calculated as previously de~cribed'~ and by a double reciprocal plot derived from the equations of Osterloh and Aisen.26 The number of receptors was computed by least squares fitting of data, using a simplex algorithm and the SYSTAT" nonlinear curve fitting routine. Two classes of binding sites were assumed, one saturable and one nonsaturable, as described by Osterloh and Aisen.26 The average value for kd, 3.9 X lo-* m o m , was used for these computations. Flow cytonetry. TfR expression was also analyzed by flow cytometry, using fluorescein isothiocyanate (FITC)-conjugated monoclonal antibodies to human TfR (anti-CD71; Immunotech, Marseilles, France). Cells were analyzed using the FACStarP1"' flow cytometer (Becton Dickinson Immunofluorometry Systems, Mountain View, CA). Cells were passed at a rate of 1,000 cells per second through a 70-mm nozzle, using saline as the sheath fluid. A 488-nm argon laser beam at 250 mW served as the light source for excitation. Green fluorescence was measured using a 530 2 30 nm band-pass filter. The photomultipliers (PMTs) were set at the appropriate voltage. Logarithmic amplification was applied At least 5 X 10' cells were analyzed.
RESULTS
Cellular uptake and use of ferritin iron. On day 7 of phase 11, uptake of s9Fe and its use for heme synthesis by the erythroid cells were determined. The results showed that 5'Fe-Ft was internalized and was incorporated into heme (Table 1 ). In the presence of excess unlabeled Ft, the uptake of "Fe-Ft was almost eliminated (Table 1 ). This could result either from competition of the labeled and unlabeled Ft for a finite number of specific receptor^'^ or alternatively, from dilution of the labeled iron by the unlabeled iron. To resolve this issue, 5ve-Ft was presented along with an excess of iron-depleted apoferritin. Apoferritin inhibited the uptake of "Fe by the cells and its incorporation into heme ( by a specific, saturable pathway that recognized the protein moiety of Ft.
The s9Fe taken up by the cells could have originated from residual non-Ft iron or from iron released from the "Fe-Ft into the medium. Such iron could subsequently be internalized following binding to Tf or albumin.2x The former possibility was unlikely because the assay was performed in serum-free, Tf-deficient, medium. The latter possibility was unlikely because the uptake and use of albumin-associated 3203 iron was different than that of Ft-(and Tf) iron ( Table l ) . Internalization of albumin-associated "Fe by the cells ( Table  1) was not diminished by addition of excess nonradioactive albumin-iron (Table l) . The lack of competition indicated that albumin-.''Fe uptake occurred by a nonspecific, nonsaturable process. This is in sharp contrast to "'Fe-Ft uptake. An excess of albumin-associated Fe did not affect the uptake of s9Fe-Ft (Table I) , providing further distinction between the uptake of '"Fe-Ft and albumin-associated "Fe.
Once internalized, '"Fe from either Ft or albumin was used for heme synthesis to the same extent (approximately 30% of uptake; Table I , lines 1 and S , respectively), whereas more of the Tf-associated s9Fe was incorporated into heme (43% of uptake). Unlabeled iron from Ft and from albumin interfered with incorporation of ""Fe from their labeled counterparts ( Table I , lines 2 and 6, respectively) . Furthermore, the internalized nonradioactive albumin-iron decreased the use of '"Fe from Ft (Table l) . Thus, regardless of the source, once internalized, the unlabeled iron diluted the internalized ""Fe.
Use of Ft-59Fe for heme synthesis was restricted to erythroid precursors because nonerythroid cells that developed in cultures without added erythropoietin did not incorporate measurable amounts of '"Fe from Ft into heme.
The &ct of Ft uptake on Tfl expression. Recognition of the internalized Ft-iron as an integral part of the cellular iron pool would result in the downregulation of TfR expression. Cells were incubated with 45 nmol/L of either holo-Ft or apo-Ft for 2 to 7 days, and TfR expression was determined. Holo-Ft caused a consistent and significant depression of TfR expression throughout the entire experimental period, as determined by both '%Tf binding (Fig 1) and by fluorescence-activated cell sorter (FACS) analysis (Figs I and 2). Apo-Ft. on the other hand, had no effect on TfR expression, which remained as in the control (data not shown).
Temporal changes in TfR and FtR expression. FtR and TfR expression were monitored during the development of the erythroid cells starting on day S of phase 11. FtR expression was determined by binding of %Ft. and TfR expression was monitored both by binding of '%Tf and by FACS analysis. The results (Fig 3) indicated that both FtR and TfR first increased, reached a peak at days 7 to 9 and then, as the cells matured, the expression of both receptors decreased.
The response of Tf and Ft receptor expression to iron statlu. Starting on day S of phase 11, cells were cultured in a complete phase 11 medium supplemented with either 0.1 mmol/L hemin or with S0 mmol/L desferrioxamine ("Desferal," DFO). Receptor expression was determined at intervals for 7 days. The results indicated that TfR expression increased in the presence of DFO and decreased in the presence of hemin (Fig 4A) . FtR expression followed a similar pattern (Fig 4B) . The effects of iron-depletion and ironloading on both FtR and TfR expression were superimposed on the temporal pattern of receptor expression established by cell development. placement assay.I5 Cells were grown for 3 days with either DFO or hemin. Subsequently, Ft binding was determined, using either increasing concentrations of Iz5I-Ft or a fixed concentration of 1251-Ft with increasing amounts of unlabeled Ft. Receptor affinity and receptor number were calculated as previously describedL5 and by the method of Osterloh and Aisen." The results indicated that receptor affinity was essentially unchanged by the treatments, whereas receptor abundance increased with iron depletion and decreased with iron-loading ( Table 2) .
DISCUSSION
We have previously demonstrated receptor-mediated specific binding and consequent internalization of acid Ft by developing erythroid ~el1s.l~ The present study shows that the internalized Ft-iron is used for heme synthesis, that the expression of the erythroid FtR is regulated by the iron status of the cell in concert with the TfR, and that the internalized Ft-iron is recognized by the cell and serves to downregulate TfR expression. The results suggest that Ft assimilation may be an additional pathway for iron delivery to developing erythroid cells.
Iron metabolism in vivo is highly regulated," whereas some of its in vitro aspects such as the uptake of hemin or of iron salts by erythroid cells, are not." For example, our present results show that TfR expression in cultures of normal human erythroid precursors is regulated by the iron status, in line with previous findings with other celk.2~5~")"3 Thus, for Ft-uptake to be a physiological iron-delivery pathway, it should provide iron for heme synthesis and be regulated by the cellular iron status and iron requirements during development in concert with the Tf-pathway.
In the present study, we showed that Ft-iron was taken up by a specific, saturable pathway, which was distinct from Tf uptake and from the nonspecific uptake of iron associated with other proteins, such as albumin. Once i n t e -, Ft-iron and albumin-associated iron were used for heme synthesis to the same extent. Iron from these two sou~ces competed for incorporation into heme, and it may be assumed that the two iron-uptake pathways converge into a common intracellular iron pool.
In a recent, preliminary study (Vaisman et a134 and manuscript submitted), Vaisman et al have shown that iron is released from intracellular Ft by a process that is inhibited by the protease inhibitors chymostatin and leupeptin. These inhibitors prevented iron use for heme synthesis. Iron not used for heme synthesis remains in ferritin at 21 hours. Chlo- roquine, an inhibitor of lysosomal function, was also found to prevent Ft-iron transfer into hemoglobin. It is, therefore, possible that a lysosomal-like compartment is involved in the uptake and processing of the internalized Ft.
Internalization of Ft resulted in the downregulation of TW expression, indicating that the cells recognize the internalized Ft-iron as a part of their iron pool for both biosynthetic purposes and regulatory functions. The effect is mediated by the iron contained in Ft and not by the protein moiety of the Ft molecule.
Our results established that during phase I1 of the culture, TW and FtR expression go through a concerted sequence of changes, coordinated to cell development. At first, receptor expression increases, reaching a peak at days 7 to 9 after the addition of erythropoietin, and subsequently decreases. During this period, cells go through a phase of intense hemoglobin synthesis that requires the supply of large amounts of iron, providing a rationale for the temporal changes in FtR and TW expression. FtR, like TW, were modulated by the cellular iron status. Thus, iron-depletion by DFO increased FtR and TW expression, whereas iron-loading by hemin addition decreased their abundance. These responses were superimposed on the temporal changes established by the cell development. The modulation in the receptor expression was manifested as a change in receptor abundance and not receptor affinity.
It is unlikely that in vivo serum Ft functions as an iron donor to erythroid cells, mainly because it is primarily basic and has a low iron content, whereas the erythroid FtR has a high specifity for acid Ft. Bessis and Breton-Gorius" suggested that Ft is transferred to erythroid cells by micropinocytosis in the local environment of the bone marrow, where the erythroid precursors are associated with a central reticuloendothelial cell in hematopoietic islands. Our results suggest that this process is receptor-mediated. Our data extend the observations of Blight and Morgan" that guinea pig reticulocytes bind and internalize Ft and use its iron for heme synthesis. However, their investigation was conducted on circulating reticulocytes, which represent the penultimate stage of erythroid development. Thus, heme synthesis has largely been completed and their cellular Ft has been used. Furthermore, their study was performed with liver Ft, which is predominantly basic and, therefore, less relevant to the human erythroid FtR, which has a higher affinity for acid iso-ferritin." The nucleated erythroid precursors used in our study were at a stage when heme synthesis is at its peak. Furthermore, our study used acid iso-ferritin, which is the high-affinity ligand of the FtR, and thus the more likely participant in the Ft-based iron uptake pathway. Current culture procedures do not allow the cells to mature to reticulocytes. Thus, we have no information as to whether Ft uptake and the changes in TW expression by Ft apply also to reticulocytes.
Hemoglobin synthesizing, developing erythroid cells have an extremely high iron requirement compared with other cells. Thus, it is not surprising that these cells possess a high capacity iron uptake system, in addition to the well known Tf-TfR system, which is present also on other cell types. Ft has the ability to convey up to 4,500 iron atoms/molecule as compared with only two atoms by each Tf molecule. Therefore, it can function as an efficient iron-delivery molecule supplementing the Tf-TfR pathway in erythroid cells. The coordinated regulation of the TW and FtR by cellular iron status, as well as during cell maturation, reflects their related activities.
The relationship of the erythroid FtR to its lymphocytic and hepatic counterparts is, as yet, unclear. The erythroid and the lymphocytic FtR seem to serve different functions: the erythroid FtR internalizes Ft, which serves as a source of iron for the cel115.L7 (and the present study), whereas the lymphocytic FtR serves a regulatory function in cell proliferation and differentiati~n.'~~~~,~~ Both receptors are specific for acid i~o -f e r r i t i n , '~~'~~~~ but their affinities for Ft differ by several orders of magnit~de.'~.'' The hepatic FtR has been purified and characteri~ed.'~.~' It is functionally similar to its erythroid counterpart, as both internalize Ft'5*26t37; it has a somewhat higher affinity for Ft,26,37 and it lacks the specificity for acid i~o -f e r r i t i n .~~.~~ Thus, erythroid FtR may be distinct from both the hepatic and the lymphocytic FtRs. The elucidation of the exact nature of the human erythroid Ft receptor and its relationship to Ft receptors on other cell types will await its isolation and cloning.
